Global Regenerative Medicine Market for Bone and Joint to Surpass US$ 14,074.3 Million by 2027, Says Coherent Market Insights (CMI)

SEATTLE–(BUSINESS WIRE)–#AllogeneicBones–According to Coherent Market Insights, the global regenerative medicine (Bone and Joint) market is estimated to be valued at US$ 7,090.1 million in 2020 and is expected to exhibit a CAGR of 10.3% over the forecast period (2020-2027).

Key Trends and Analysis:

Major players in the global regenerative medicine (bone and joint) market are focused on approvals and launches of new products to expand their product portfolio in the market. For instance, in July 2020, Baxter International Inc, announced that they received the U.S. Food Drug Administration clearance for its Altapore Shape bioactive bone graft for bone growth and fusion. Altapore Shape is used as a standalone bone graft substitute or as an autograft extender to fill bony voids or gaps in the skeletal system caused by trauma including those within the pelvis, extremities, and the posterolateral spine.

Moreover, rising research and development for new regenerative products is expected to offer lucrative growth opportunities for players in the global regenerative medicine (bone and joint) market. For instance, in June 2019, Personalized Stem Cells, Inc. submitted an Investigational New Drug Application (IND) to the U.S. FDA for utilizing patients’ own adipose-derived stem cells to treat their osteoarthritis.

Among regions, North America regenerative medicine (bone and joint) market is expected to hold dominant position in the market during the forecast period, owing to increasing commercialization activities of regenerative medicine products by key players in the U.S. For instance, in May 2018, Medtronic announced that the U.S. Food and Drug Administration (FDA) approved Infuse Bone Graft in new spine surgery indications with additional spine implants made of polyetheretherketone (PEEK) in oblique lateral interbody fusion (OLIF 25 and OLIF 51) and anterior lumbar interbody fusion (ALIF) procedures.

Buy-Now this Research Report for detailed market insights @ https://www.coherentmarketinsights.com/insight/buy-now/3566

Key Market Takeaways:

The global regenerative medicine (Bone and Joint) market is expected to exhibit a CAGR of 10.3% over the forecast period, owing to increasing number of product launches and approval by regulatory bodies. For instance, in January 2020, Royal Biologics launched Magnus viable cellular bone matrix, which is an osteoconductive bone scaffold and is composed of demineralized cortical, mineralized cortical, and cancellous bone that are stored in a Dimethyl sulfoxide (DMSO)-free cryoprotectant.

Competitive Landscape:

Key players operating in the global regenerative medicine (Bone and Joint) market include Anika Therapeutics, Inc, Arthrex, Inc., Baxter International, Inc., CONMED Corporation, Johnson & Johnson, Medtronic, Plc, Smith & Nephew plc, Stryker Corporation, Zimmer Holdings, Inc., Aziyo Biologics, and Ortho Regenerative Technologies Inc.

Request Sample Copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/3566

Market Segmentation:

• Global Regenerative Medicine (Bone and Joint) Market, By Technology :
  • Stem Cell
  • Biomaterial
  • Tissue Engineering
• Global Regenerative Medicine (Bone and Joint) Market, By Application :
  • Bone Graft Substitutes
  • Osteoarticular Diseases
  • Allogeneic Bones
  • Autogenic Bones
  • Others
• Global Regenerative Medicine (Bone and Joint) Market, By Region:
  • North America
    • By Country:
      • U.S.
      • Canada
  • Latin America
    • By Country:
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • By Country:
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • By Country:
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • By Country/Region:
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • By Country/Region:
      • South Africa
      • Central Africa
      • North Africa

Related Market Intelligence Reports:

Stem Cells Market, By Type (Adult Stem Cells, Human Embryonic Stem Cells, Induced Pluripotent Stem Cells, Natural Rosette Cells, Very Small Embryonic Like Stem Cells), By Application (Regenerative Medicine, Drug Discovery and Development), By Technology (Cell Acquisition, Cell Production, Cryopreservation, Expansion and Sub-Culture), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) – Size, Share, Outlook, and Opportunity Analysis, 2020 – 2027

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. Our client base includes players from across various business verticals in over 57 countries worldwide.

Contacts

Mr. Shah

Senior Client Partner – Business Development

Coherent Market Insights

Phone:
US: +1-206-701-6702

UK: +44-020-8133-4027

Japan: +81-050-5539-1737

India: +91-848-285-0837

Email: sales@coherentmarketinsights.com
Website: https://www.coherentmarketinsights.com
Follow Us: LinkedIn | Twitter